Davidson Kempner Capital Management LP Jazz Pharmaceuticals PLC Transaction History

Davidson Kempner Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	BUY	$160.2 - $186.42 $3.38 Million - $3.93 Million	21,075 Added 5.45%	407,871 $72.5 Million
Q1 2021 May 17, 2021	SELL	$150.19 - $173.5 $11.5 Million - $13.3 Million	-76,407 Reduced 16.5%	386,796 $63.6 Million
Q4 2020 Feb 16, 2021	SELL	$140.71 - $165.05 $63.5 Million - $74.4 Million	-450,988 Reduced 49.33%	463,203 $76.5 Million
Q3 2020 Nov 16, 2020	BUY	$105.46 - $144.13 $46.9 Million - $64.2 Million	445,161 Added 94.91%	914,191 $130 Million
Q2 2020 Aug 14, 2020	BUY	$95.68 - $121.88 $44.9 Million - $57.2 Million	469,030 New	469,030 $51.8 Million

511

57.6M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.57B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Davidson Kempner Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Davidson Kempner Capital Management LP with notifications on news.